Lavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial Carcinoma (LUSTIC)
Pilot Study of the Lavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial Carcinoma
Sponsor: Medical University of Vienna
This NA trial investigates Carcinoma in Situ and Ovarian Cancer and is currently completed. Medical University of Vienna leads this study, which shows 10 recorded versions since 2013 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2022 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
May 2021 — Sep 2022 [monthly]
Recruiting NA
-
Jan 2021 — May 2021 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Mar 2020 — Jan 2021 [monthly]
Recruiting NA
-
Jun 2019 — Mar 2020 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting
-
Jul 2018 — Jun 2019 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jun 2018 — Jul 2018 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Nov 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medical University of Vienna
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Berlin, Germany , Brno, Czechia , Copenhagen, Denmark , Dublin, Ireland , Essen, Germany , Graz, Austria , Leuven, Belgium , Linz, Austria , London, United Kingdom , München, Germany and 4 more locations